Israeli norms for the Stanford Hypnotic Susceptibility Scale, Form C

International Journal of Clinical and Experimental Hypnosis

Volumn 57, Issue 2, 2009, Pages 227-237

  Lichtenberg, Pesach ^a,e   Shapira, Haim ^b   Kalish, Yuval ^c   Abramowitz, Eitan G ^d  

^a HEBREW UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MEDICAL CORPS   (Israel)

^e HERZOG HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; FEMALE; GERMANY; HUMAN; HUMAN EXPERIMENT; HYPNOTIC SUSCEPTIBILITY; ISRAEL; ITALY; MALE; MEXICO; NORMAL HUMAN; RATING SCALE; RELIABILITY; SPAIN; STANFORD HYPNOTIC SUSCEPTIBILITY SCALE FORM C; UNITED STATES;

HUMANS; HYPNOSIS; ISRAEL; QUESTIONNAIRES; REFERENCE VALUES; SUGGESTION;

EID: 61649108160     PISSN: 00207144     EISSN: 17445183     Source Type: Journal    
DOI: 10.1080/00207140802665492     Document Type: Article

References (14)

1. Bongartz, W. (2000). Deutsche Normen für die Stanford Hypnotic Susceptibility Scale, Form C (SHSS:C) [German norms for the Stanford Hypnotic Susceptibility Scale, Form C (SHSS:C)]. Experimentelle und Klinische Hypnose, 16, 123-133.
2. Brodeur, J. B., Kurtz, R. M., & Strube, M. J. (1998). Hypnotic susceptibility order effects in waking analgesia. International Journal of Clinical and Experimental Hypnosis, 46, 240-249.
3. De Pascalis, V., Bellusci, A., & Russo, P. M. (2000). Italian norms for the Stanford Hypnotic Susceptibility Scale, Form C. International Journal of Clinical and Experimental Hypnosis, 48, 315-323.
4. Hilgard, E. (1965). Hypnotic susceptibility. New York: Harcourt, Brace & World.
5. Lamas, J. R., del Valle-Inclán, F., & Diaz, A. A. (1996). Datos normativos de la Escala de Susceptibilidad Hipnotica de Stanford, Forma C, en una muestra espanola [Spanish norms for the Stanford Hypnotic Susceptibility Scale, Form C]. Psicothema, 8, 369-373.
6. Levin, R., Bar, G., Lichtenberg, P., Shapiro, H., Ermilov, M., Catinari, S., et al. (2007). Genetic, biochemical and behavioral correlates of the prepulse inhibition paradigm. Neurodegenerative Diseases: From the bench to the clinic. Fourth triennial seminar, Maale Hahamisha, Israel.
7. Lichtenberg, P., Bachner-Melman, R., Ebstein, R. P., & Crawford, H. J. (2004). Hypnotic susceptibility: Multidimensional relationships with Cloninger's tridimensional personality questionnaire, COMT polymorphisms, absorption and attentional characteristics. International Journal of Clinical and Experimental Hypnosis, 52, 47-72.
8. Lichtenberg, P., Even-Or, E., Bar, G., Levin, R., Brin, A., & Heresco-Levy, U. (2008). Reduced prepulse inhibition is associated with increased hypnotizability. International Journal of Neuropsychopharmacology, 11, 541-545.
9. Matthews, W. J., & Isenberg, G. L. (1995). A comparison of the hypnotic experience between signing deaf and hearing participants. International Journal of Clinical and Experimental Hypnosis, 43, 375-385.
10. Näring, G. W., Hoogduin, C. A. L., & Keijser, C. M. (2004). A Rasch analysis of the Stanford Hypnotic Susceptibility Scale, Form C. International Journal of Clinical and Experimental Hypnosis, 52, 250-259.
11. Näring, G. W., Roelofs, K., & Hoogduin, C. A. L. (2001). The Stanford Hypnotic Susceptibility Scale, Form C: Normative data of a Dutch student sample. International Journal of Clinical and Experimental Hypnosis, 49, 139-145.
12. Sánchez-Armáss, O., & Barabasz, A. F. (2005). Mexican norms for the Stanford Hypnotic Susceptibility Scale, Form C. International Journal of Clinical and Experimental Hypnosis, 53, 321-331.
13. Shor, R. E., & Orne, E. C. (1962). The Harvard Group Scale of Hypnotic Susceptibility. Palo Alto, CA: Consulting Psychologists Press.
14. Weitzenhoffer, A. M., & Hilgard, E. R. (1962). Stanford Hypnotic Susceptibility Scale, Form C. Palo Alto, CA: Consulting Psychologists Press.